RCAN3, a novel calcineurin inhibitor that down-regulates NFAT-dependent cytokine gene expression - PubMed (original) (raw)
. 2007 Mar;1773(3):330-41.
doi: 10.1016/j.bbamcr.2006.12.007. Epub 2006 Dec 21.
Affiliations
- PMID: 17270291
- DOI: 10.1016/j.bbamcr.2006.12.007
Free article
RCAN3, a novel calcineurin inhibitor that down-regulates NFAT-dependent cytokine gene expression
M Carme Mulero et al. Biochim Biophys Acta. 2007 Mar.
Free article
Abstract
The regulators of calcineurin (RCAN) proteins, previously known as calcipressins, have been considered to be a well conserved family from yeast to human based on the conservation of their FLISPP motif. Here, after performing a RCAN comparative genomic analysis we propose the existence of a novel functionally closely related RCAN subfamily restricted to vertebrates, the other RCAN proteins being considered only as distantly related members of the family. In addition, while three paralogous RCAN genes are found in vertebrates, there is only one in the other members of Eukarya. Moreover, besides the FLISPP motif, these paralogous genes have two others conserved motifs, the Cn-inhibitor RCAN (CIC) and the PxIxxT, which are restricted to vertebrates. In humans, RCAN1 and RCAN2 bind and inhibit Cn through their C-terminal region. Given the high amino acid identity in this region among human RCANs, authors in the field have hypothesized a role for RCAN3 in inhibiting Cn activity. Here, we demonstrate for the first time that human RCAN3, encoded by the RCAN3 (also known as DSCR1L2) gene, interacts physically and functionally with Cn. This interaction takes place only through the RCAN3 CIC motif. Overexpression of this sequence inhibits Cn activity towards the nuclear factor of activated T cells (NFAT) transcription factors and down-regulates NFAT-dependent cytokine gene expression in activated human Jurkat T cells.
Similar articles
- Protein kinase CK2-dependent phosphorylation of the human Regulators of Calcineurin reveals a novel mechanism regulating the calcineurin-NFATc signaling pathway.
Martínez-Høyer S, Aranguren-Ibáñez A, García-García J, Serrano-Candelas E, Vilardell J, Nunes V, Aguado F, Oliva B, Itarte E, Pérez-Riba M. Martínez-Høyer S, et al. Biochim Biophys Acta. 2013 Oct;1833(10):2311-21. doi: 10.1016/j.bbamcr.2013.05.021. Epub 2013 Jun 1. Biochim Biophys Acta. 2013. PMID: 23732701 - A novel role for an RCAN3-derived peptide as a tumor suppressor in breast cancer.
Martínez-Høyer S, Solé-Sánchez S, Aguado F, Martínez-Martínez S, Serrano-Candelas E, Hernández JL, Iglesias M, Redondo JM, Casanovas O, Messeguer R, Pérez-Riba M. Martínez-Høyer S, et al. Carcinogenesis. 2015 Jul;36(7):792-9. doi: 10.1093/carcin/bgv056. Epub 2015 Apr 26. Carcinogenesis. 2015. PMID: 25916653 - The PxIxIT motif of the RCAN3 inhibits angiogenesis and tumor progression in Triple Negative breast cancer in immunocompetent mice.
Biçer A, López-Henares P, Molero-Magariño M, Feu-Llauradó A, Sabariego-Navarro M, Bayod S, Padilla L, Taco MR, Larriba S, Pérez-Riba M, Serrano-Candelas E. Biçer A, et al. Carcinogenesis. 2022 Sep 19;43(8):808-812. doi: 10.1093/carcin/bgac049. Carcinogenesis. 2022. PMID: 35640493 - Regulator of Calcineurin (RCAN): Beyond Down Syndrome Critical Region.
Lee SK, Ahnn J. Lee SK, et al. Mol Cells. 2020 Aug 31;43(8):671-685. doi: 10.14348/molcells.2020.0060. Mol Cells. 2020. PMID: 32576715 Free PMC article. Review. - Inhibition of the calcineurin-NFAT signalling cascade in the treatment of heart failure.
Panther F, Williams T, Ritter O. Panther F, et al. Recent Pat Cardiovasc Drug Discov. 2009 Nov;4(3):180-6. doi: 10.2174/157489009789152276. Recent Pat Cardiovasc Drug Discov. 2009. PMID: 19925438 Review.
Cited by
- A central role for calcineurin in protein misfolding neurodegenerative diseases.
Shah SZ, Hussain T, Zhao D, Yang L. Shah SZ, et al. Cell Mol Life Sci. 2017 Mar;74(6):1061-1074. doi: 10.1007/s00018-016-2379-7. Epub 2016 Sep 28. Cell Mol Life Sci. 2017. PMID: 27682820 Free PMC article. Review. - GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation.
Park MJ, Lee SH, Lee SH, Kim EK, Lee EJ, Moon YM, La Cho M. Park MJ, et al. J Transl Med. 2016 Jul 8;14(1):206. doi: 10.1186/s12967-016-0963-0. J Transl Med. 2016. PMID: 27391226 Free PMC article. - Astroglial calcium signaling and homeostasis in tuberous sclerosis complex.
Romagnolo A, Dematteis G, Scheper M, Luinenburg MJ, Mühlebner A, Van Hecke W, Manfredi M, De Giorgis V, Reano S, Filigheddu N, Bortolotto V, Tapella L, Anink JJ, François L, Dedeurwaerdere S, Mills JD, Genazzani AA, Lim D, Aronica E. Romagnolo A, et al. Acta Neuropathol. 2024 Feb 28;147(1):48. doi: 10.1007/s00401-024-02711-3. Acta Neuropathol. 2024. PMID: 38418708 Free PMC article. - NFAT gene family in inflammation and cancer.
Pan MG, Xiong Y, Chen F. Pan MG, et al. Curr Mol Med. 2013 May;13(4):543-54. doi: 10.2174/1566524011313040007. Curr Mol Med. 2013. PMID: 22950383 Free PMC article. Review. - Basal bioenergetic abnormalities in skeletal muscle from ryanodine receptor malignant hyperthermia-susceptible R163C knock-in mice.
Giulivi C, Ross-Inta C, Omanska-Klusek A, Napoli E, Sakaguchi D, Barrientos G, Allen PD, Pessah IN. Giulivi C, et al. J Biol Chem. 2011 Jan 7;286(1):99-113. doi: 10.1074/jbc.M110.153247. Epub 2010 Oct 26. J Biol Chem. 2011. PMID: 20978128 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous